Prudential Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.51M | Buy |
415,143
+350,504
| +542% | +$1.28M | ﹤0.01% | 1502 |
|
2025
Q1 | $124K | Buy |
64,639
+170
| +0.3% | +$326 | ﹤0.01% | 2109 |
|
2024
Q4 | $122K | Hold |
64,469
| – | – | ﹤0.01% | 2131 |
|
2024
Q3 | $85.1K | Buy |
64,469
+50,200
| +352% | +$66.3K | ﹤0.01% | 2594 |
|
2024
Q2 | $14.6K | Sell |
14,269
-23,840
| -63% | -$24.3K | ﹤0.01% | 2677 |
|
2024
Q1 | $69.7K | Buy |
38,109
+16,000
| +72% | +$29.3K | ﹤0.01% | 2562 |
|
2023
Q4 | $27.4K | Sell |
22,109
-25,400
| -53% | -$31.5K | ﹤0.01% | 2600 |
|
2023
Q3 | $54.2K | Hold |
47,509
| – | – | ﹤0.01% | 2494 |
|
2023
Q2 | $43.5K | Buy |
+47,509
| New | +$43.5K | ﹤0.01% | 2546 |
|
2022
Q2 | – | Sell |
-249,912
| Closed | -$177K | – | 2658 |
|
2022
Q1 | $177K | Sell |
249,912
-381,000
| -60% | -$270K | ﹤0.01% | 2519 |
|
2021
Q4 | $1.43M | Sell |
630,912
-452,993
| -42% | -$1.02M | ﹤0.01% | 1707 |
|
2021
Q3 | $3.12M | Buy |
1,083,905
+1,062,864
| +5,051% | +$3.06M | ﹤0.01% | 1227 |
|
2021
Q2 | $80K | Buy |
21,041
+2,655
| +14% | +$10.1K | ﹤0.01% | 2503 |
|
2021
Q1 | $62K | Buy |
18,386
+60
| +0.3% | +$202 | ﹤0.01% | 2452 |
|
2020
Q4 | $51K | Hold |
18,326
| – | – | ﹤0.01% | 2409 |
|
2020
Q3 | $46K | Buy |
18,326
+6,659
| +57% | +$16.7K | ﹤0.01% | 2390 |
|
2020
Q2 | $158K | Buy |
+11,667
| New | +$158K | ﹤0.01% | 2294 |
|
2020
Q1 | – | Sell |
-12,760
| Closed | -$81K | – | 2347 |
|
2019
Q4 | $81K | Buy |
12,760
+1,600
| +14% | +$10.2K | ﹤0.01% | 2384 |
|
2019
Q3 | $44K | Buy |
11,160
+1,143
| +11% | +$4.51K | ﹤0.01% | 2384 |
|
2019
Q2 | $48K | Sell |
10,017
-12,540
| -56% | -$60.1K | ﹤0.01% | 2423 |
|
2019
Q1 | $185K | Sell |
22,557
-2,476
| -10% | -$20.3K | ﹤0.01% | 2328 |
|
2018
Q4 | $138K | Buy |
25,033
+6,673
| +36% | +$36.8K | ﹤0.01% | 2281 |
|
2018
Q3 | $162K | Sell |
18,360
-410
| -2% | -$3.62K | ﹤0.01% | 2355 |
|
2018
Q2 | $187K | Buy |
+18,770
| New | +$187K | ﹤0.01% | 2350 |
|
2017
Q4 | – | Sell |
-49,360
| Closed | -$971K | – | 2329 |
|
2017
Q3 | $971K | Buy |
+49,360
| New | +$971K | ﹤0.01% | 1844 |
|